expert roundtables by Leonard H. Calabrese, DO; Jeffrey R. Curtis, MD, MS, MPH; and Eric M. Ruderman, MD
Emerging technologies are improving the identification of patients with preclinical rheumatoid arthritis (RA) and those who are at risk for develop......READ MORE
clinical topic updates by Jeffrey R. Curtis, MD, MS, MPH
Cardiovascular (CV) events are more likely to occur in patients with rheumatoid arthritis (RA) than in those without RA, an effect that is likely r......READ MORE
clinical topic updates by Leonard H. Calabrese, DO
The diagnosis of seronegative rheumatoid arthritis (RA) is challenging, as there are many potential diseases that can mimic RA. Ruling out these al......READ MORE
expert roundtables by Leonard H. Calabrese, DO, Jeffrey R. Curtis, MD, MS, MPH, Eric M. Ruderman, MD
Pathobiology-guided therapy has long been a goal in the treatment of patients with rheumatoid arthritis (RA). Despite limited success in the past, ......READ MORE
expert roundtables by Leonard H. Calabrese, DO, Jeffrey R. Curtis, MD, MS, MPH, Eric M. Ruderman, MD
Patients with rheumatoid arthritis (RA) who have continued moderate disease activity despite receiving biologic therapy are an important clinical d......READ MORE
The fields of rheumatology and radiology are changing rapidly. Potential roles for imaging in rheumatoid arthritis (RA) include assisting in early ......READ MORE
